These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The characteristics of macular branch retinal vein occlusion].
    Author: Zhang H, An W, Lei J.
    Journal: Zhonghua Yan Ke Za Zhi; 1996 Nov; 32(6):441-4. PubMed ID: 9590813.
    Abstract:
    OBJECTIVE: The study was designed for the analysis on data of 51 patients with macular branch retinal vein occlusion (McBRVO) and the comparison between them and 210 patients (214 eyes) with major branch retinal vein occlusion (MjBRVO). METHODS: Fluorescein angiography, ophthalmoscope and slit-lamp were used for the examination of the venous obstructive site and the locations of artery and vein. RESULTS: (1) The incidence of McBRVO was 19.5% (51/261) in branch retinal vein occlusion. (2) The site of occlusion: the incidence of McBRVO at supero-temporal branches was 72.5% (37/51) and the incidence of MjBRVO was 73.4% (157/214). (3) The involved branch at the first macular branch accounted for 39.6%, the second branch 58.3%, and the third branch 2.1%. The artery anterior to the vein at arteriovenous crossing at the obstructive site accounted for 93.0% in the McBRVO group and 95.0% in the MjBRVO group. (4) The complications and visual prognosis: The incidence of cystoid macular edema was 20.0% in McBRVO group and that was 28.5% in the MjBRVO group. No neovascularization was found in the McBRVO group, while 37.9% neovascular formation was found in the MjBRVO group. The visual acuity recovered to 0.5 or better was in 88.2% in the McBRVO group, while 57.0% in the MjBRVO group (P < 0.005). CONCLUSION: There are no significant differences in sex, age, laterality, pathogenesis as well as occlusion site between the McBRVO and MjBRVO groups, but the visual prognosis is better in the former than that in the latter group.
    [Abstract] [Full Text] [Related] [New Search]